Denmark Migraine Drugs Market Size & Outlook, 2025-2030
Related Markets
Denmark migraine drugs market highlights
- The Denmark migraine drugs market generated a revenue of USD 37.1 million in 2024 and is expected to reach USD 63.2 million by 2030.
- The Denmark market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, otc was the largest revenue generating product in 2024.
- OTC is the most lucrative product segment registering the fastest growth during the forecast period.
Migraine drugs market data book summary
| Market revenue in 2024 | USD 37.1 million |
| Market revenue in 2030 | USD 63.2 million |
| Growth rate | 9.3% (CAGR from 2025 to 2030) |
| Largest segment | Otc |
| Fastest growing segment | OTC |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC, Prescription |
| Key market players worldwide | GlaxoSmithKline, Pfizer Inc, AbbVie Inc, Amgen Inc, Eli Lilly and Co, Teva Pharmaceutical Industries Ltd, Biohaven Ltd, Johnson & Johnson, Bausch Health Companies Inc |
Other key industry trends
- In terms of revenue, Denmark accounted for 0.5% of the global migraine drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany migraine drugs market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 553.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Migraine Drugs Market Scope
Migraine Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biohaven Ltd | View profile | 239 | 215 Church Street, New Haven, CT, United States, 06510 | https://www.biohavenpharma.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Denmark migraine drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to migraine drugs market will help companies and investors design strategic landscapes.
Otc was the largest segment with a revenue share of 62.53% in 2024. Horizon Databook has segmented the Denmark migraine drugs market based on otc, prescription covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Denmark migraine drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Denmark migraine drugs market databook
-
Our clientele includes a mix of migraine drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark migraine drugs market , including forecasts for subscribers. This country databook contains high-level insights into Denmark migraine drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Denmark Product - Migraine Drugs Market size, 2024 - 2030 (US$M)
Denmark Migraine Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
